COc1ccc(C2(C)NC(=O)N(CC(=O)Nc3ccc4[nH]c(O)nc4c3)C2=O)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?